OGN

XNYS

ORGANON & CO

Avg. sentiment
-0.10neutral

2 news · 90d

7d trend

0 news · vs previous 7d ()

Breakdown
020
Sentiment velocity
+0.043/day

Acceleration +0.043 (vs prior 7d)

No price data available for this ticker.

Daily digest

Track $OGN sentiment without checking the page.

Top-discussed tickers and the AI sentiment we read. Not advice.

  • May 03 15:15→ 0.10SeekingAlpharel 50%
    Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more

    A SeekingAlpha roundup article highlights key deals of the week involving Organon, ARC Resources, Nebius, and Eli Lilly among others. The article is a curated recap of multiple transactions across different companies and sectors. No single new deal is broken or confirmed within the article itself.

  • Apr 30 11:30→ 0.30BusinessWirerel 100%
    Organon Reports Results for the First Quarter Ended March 31, 2026

    Organon (OGN) reported Q1 2026 revenue of $1.46 billion, down 4% year-over-year (down 9% excluding foreign exchange), missing the prior-year period's $1.513 billion. Women's Health revenue declined 16% to $389 million, while Biosimilars grew 23% to $173 million; Established Brands were roughly flat at $880 million.